Pieris Pharmaceuticals, Inc. has appointed Allan Reine as Senior Vice President and Chief Financial Officer, effective August 9, 2017. Dr. Reine is an accomplished healthcare investor and brings to Pieris a wealth of capital markets experience, a deep biotech background, and a strong scientific acumen. Prior to joining Pieris, from 2012 through August 2017, Dr. Reine was a portfolio manager at Lombard Odier Asset Management, where he ran a healthcare portfolio focused on biotechnology and pharmaceutical companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.15 USD | +3.70% | -3.15% | -30.29% |
1st Jan change | Capi. | |
---|---|---|
-30.29% | 13.4M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
+0.09% | 21.96B | |
-8.17% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Appoints Allan Reine as Senior Vice President and Chief Financial Officer